Satellite Symposia

Monday May 15, 2017 - Symposium presented by Novo Nordisk

16:00-17:30 New therapeutic approaches to address cardiovascular risk in diabetic patients
Chairperson: André Carpentier
Objectives
  • Review the mechanisms of the beneficial effects of PCSK9 inhibitors, GLP-1 agonists and SGLT2 inhibitors on cardiovascular health;
  • Review recent cardiovascular studies on these classes of drugs;
  • Discuss the role of these pharmacological agents in the management of cardiometabolic risk.
16:00-16:05 Introduction André Carpentier
16:05-16:30 PCSK9 inhibitors Robert Dufour
16:30-16:55 GLP-1 agonists John Weisnagel
16:55-17:20 SGLT2 inhibitors André Carpentier
17:20-17:30 Panel discussion Faculty
18:00-21:00 Opening Ceremony and Welcome Party

Visit our social networks

Important Dates

Registration opening
November 1, 2016
Abstract submission opening
November 1, 2016
Abstract submission deadline
February 25, 2017
Notification of acceptance
March 13, 2017
Registration for presenting authors
April 2, 2017
Early bird registration
April 2, 2017

Newsletter